Association between Inflammatory Gene Polymorphisms and the Risk of Myocardial Infarction

被引:7
作者
Nasibullin, T. R. [1 ]
Sadikova, R. I. [1 ]
Timasheva, Ya. R. [1 ]
Tuktarova, I. A. [1 ]
Erdman, V. V. [1 ]
Khusainova, L. N. [2 ]
Nikolaeva, I. E. [3 ]
Mustafina, O. E. [1 ]
机构
[1] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450054, The Republic Of, Russia
[2] Hosp Bashkir State Med Univ, Ufa 450059, Russia
[3] Republican Cardiol Hlth Ctr, Ufa 450106, Russia
基金
俄罗斯基础研究基金会;
关键词
MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORONARY-HEART-DISEASE; ENDOTHELIAL-CELLS; E-SELECTIN; ATHEROSCLEROSIS; EXPRESSION; GAMMA; K469E; LDL;
D O I
10.1134/S1022795414020112
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Allele and genotype frequency distributions of polymorphism rs2076059 (3832T>C) within the SELE gene, rs6131 (S290N), within the SELP gene, rs1131498 (F206L), within the SELL gene, rs5498 (K469E) within the ICAM1 gene, rs35569394 (-2549(18)I/D) within the VEGFA gene, and rs1024611 (-2518A>G) within the CCL2 gene were examined in a group of patients after myocardial infarction (MI)(280 individuals) and in a control group (312 individuals). An implementation of the Markov chain and Monte-Carlo method (APSampler) revealed the allele combinations associated with decreased and increased risk of MI. Among these, the most important allele combinations were SELE*C + SELP*S + CCL2*A (FDR = 0.0005; OR = 0.42), SELP*S + CCL2*A (FDR = 0.0009; OR = 0.36), SELL*F + VEGFA*I + CCL2*G/G (FDR = 0.0009; OR = 4.17), VEGFA*I + CCL2*G/G (FDR = 0.0009; OR = 3.76), SELE*C + CCL2*A (FDR = 0.0023; OR = 0.47), and SELL*F + CCL2*G/G (FDR = 0.003; OR = 3.15).
引用
收藏
页码:211 / 217
页数:7
相关论文
共 35 条
[1]  
[Anonymous], 1989, Molecular Cloning: A Laboratory
[2]   Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1) [J].
Bielinski, Suzette J. ;
Reiner, Alex P. ;
Nickerson, Deborah ;
Carlson, Chris ;
Bailey, Kent R. ;
Thyagarajan, Bharat ;
Lange, Leslie A. ;
Boerwinkle, Eric A. ;
Jacobs, David R., Jr. ;
Gross, Myron D. .
ATHEROSCLEROSIS, 2011, 216 (02) :390-394
[3]   Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients [J].
Bleda, Silvia ;
De Haro, Joaquin ;
Varela, Cesar ;
Esparza, Leticia ;
Ferruelo, Antonio ;
Acin, Francisco .
DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (01) :68-74
[4]  
Bucova M, 2009, BRATISL MED J, V110, P385
[5]   The intercellular adhesion molecule-1 (ICAM-1) gene polymorphism K469E in end-stage renal disease patients with cardiovascular disease [J].
Buraczynska, Monika ;
Zaluska, Wojciech ;
Baranowicz-Gaszczyk, Iwona ;
Buraczynska, Kinga ;
Niemczyk, Ewa ;
Ksiazek, Andrzej .
HUMAN IMMUNOLOGY, 2012, 73 (08) :824-828
[6]   Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England [J].
Eaton, Charles B. ;
Gramling, Robert ;
Parker, Donna R. ;
Roberts, Mary B. ;
Lu, Bing ;
Ridker, Paul M. .
ATHEROSCLEROSIS, 2008, 200 (01) :221-227
[7]   A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases in humans [J].
Favorov, AV ;
Andreewski, TV ;
Sudomoina, MA ;
Favorova, OO ;
Parmigiani, G ;
Ochs, MF .
GENETICS, 2005, 171 (04) :2113-2121
[8]   Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes - A regulatory role for plasma LDL [J].
Han, KH ;
Tangirala, RK ;
Green, SR ;
Quehenberger, O .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1983-1991
[9]   Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction [J].
Hayashidani, S ;
Tsutsui, H ;
Shiomi, T ;
Ikeuchi, M ;
Matsusaka, H ;
Suematsu, N ;
Wen, J ;
Egashira, K ;
Takeshita, A .
CIRCULATION, 2003, 108 (17) :2134-2140
[10]   Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ [J].
Inoue, M ;
Itoh, H ;
Tanaka, T ;
Chun, TH ;
Doi, K ;
Fukunaga, Y ;
Sawada, N ;
Yamshita, J ;
Masatsugu, K ;
Saito, T ;
Sakaguchi, S ;
Sone, M ;
Yamahara, K ;
Yurugi, T ;
Nakao, K .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :560-566